BAKER BROS ADVISORS LLC
667 MADISON AVE, NEW YORK, New York, 10065, (212) 339-5600
Report Date: 03/31/2013
Position Statistics:
| Total Positions | 67 |
| New Positions | 8 |
| Increased Positions | 20 |
| Decreased Positions | 16 |
| Positions with Activity | 36 |
| Sold Out Positions | 5 |
| Total Mkt Value (in $ millions) |
3,968 |
Sector Weighting
| Basic Materials | |
| Capital Goods | |
| Conglomerates | 0.09% |
| Consumer Cyclical | |
| Consumer/Non-Cyclical | |
| Energy | |
| Financial | |
| Healthcare | 99.91% |
| Services | |
| Technology | |
| Transportation | |
| Utilities |
Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission.
67 Positions as of 03/31/2013
| Company | Class | Value of Shares ($1,000s) |
Change in Value ($1,000s) | Change (%) | Shares Held |
|---|---|---|---|---|---|
| PHARMACYCLICS INC | COM | 927,324 | -44,188 | (4.55) | 10,923,830 |
| SEATTLE GENETICS INC | COM | 709,152 | New | 19,322,947 | |
| GENOMIC HEALTH INC | COM | 468,503 | 8,100 | 1.76 | 12,577,272 |
| SYNAGEVA BIOPHARMA CORP | COM | 367,728 | 34,277 | 10.28 | 9,223,182 |
| INCYTE CORP | COM | 341,235 | New | 14,810,559 | |
| VIROPHARMA INC | COM | 220,720 | -12,854 | (5.5) | 8,528,603 |
| ACADIA PHARMACEUTICALS | COM | 207,301 | New | 15,621,812 | |
| XOMA CORP DEL | COM | 85,559 | New | 20,274,581 | |
| AEGERION PHARMACEUTICALS INC | COM | 53,181 | 15,347 | 40.56 | 863,743 |
| BIOMARIN PHARMACEUTICAL INC | COM | 50,140 | 37,310 | 290.81 | 783,311 |
| REPROS THERAPEUTICS INC | COM NEW | 37,739 | 12,736 | 50.94 | 2,261,154 |
| CLOVIS ONCOLOGY INC | COM | 36,953 | -4,208 | (10.22) | 1,001,163 |
| CERUS CORP | COM | 35,855 | 24,295 | 210.16 | 6,542,845 |
| ARIAD PHARMACEUTICALS INC | COM | 35,841 | 349 | .98 | 2,150,000 |
| AUXILIUM PHARMACEUTICALS INC | COM | 31,650 | -33,960 | (51.76) | 2,108,617 |
| INFINITY PHARMACEUTICALS INC | COM | 29,356 | New | 1,178,485 | |
| MEDIVATION INC | COM | 25,425 | -20,515 | (44.66) | 534,919 |
| HALOZYME THERAPEUTICS INC | COM | 25,331 | 11,243 | 79.81 | 3,182,251 |
| VERTEX PHARMACEUTICALS INC | COM | 20,063 | 20,063 | New | 252,400 |
| DERMA SCIENCES INC | COM PAR $.01 | 19,418 | New | 1,358,857 |
Latest News Headlines
ISS Supports Both Moab Nominees to Replace Mac-Gray's Incumbent Directors 1:00PM ET - GlobeNewswire
TXI Achieves Operational Status of New Kiln Line and Accelerates Upgrade Projects at the Hunter Cem 12:56PM ET - GlobeNewswire
Professional Diversity Network Names Michael R. Hernandez Chief Marketing & Communications Officer 12:55PM ET - GlobeNewswire
UPDATE: GE Capital Plans to Pay Parent GE $6.5 Billion 2013 Dividend 12:53PM ET - Dow Jones Business News
Citi Names New CEOs of CitiMortgage, Private Bank and Citi Holdings -Memo 12:35PM ET - Dow Jones Business News
View All